Medical/Pharmaceuticals
Pharmaxis Cleared To Progress To Phase 2 Bone Marrow Cancer Trial
SYDNEY, Oct. 5, 2021 /PRNewswire/ -- Clinical stage drug development company Pharmaxis Ltd (ASX: PXS) today announced further positive results of data analysis from a phase 1c clinical trial (MF-101) studying its drug PXS-5505 in patients with the bone marrow cancer myelofibrosis for 28 days at t...
2021-10-05 18:00
2468
New clinical trial shows 53% reduction of ventilator-associated pneumonia with Bactiguard's endotracheal tube
STOCKHOLM, Oct. 5, 2021 /PRNewswire/ -- This week at the European Society of Intensive Care congress (ESICM), a study from Liège,Belgium on Bactiguard's endotracheal tubes was presented. The study showed a 53% reduction in ventilator-associated pneumonia (VAP) in intensive care patients, intubate...
2021-10-05 14:38
2447
New, Unpublished Data Reveals Impact of COVID-19 in Patients With Neurological Disorders; Renowned Neuroscientist Ettore Beghi Presents Findings in "Special Lecture on Neuro COVID," Oct 4, 2021, World Congress of Neurology 2021
LONDON, Oct. 5, 2021 /PRNewswire/ -- New data for the first time reveals a connection between COVID-19 and its worsening impact on patients with existing neurological conditions. Newly released research identifying distinct profiles of COVID-19 patients with neurological conditions and manifestat...
2021-10-05 14:27
1751
Dr Joshua Loh Shares New and Advanced Percutaneous Coronary Intervention (PCI) Techniques in 2021 to Treat Coronary Heart Disease - a Major Cause of Death in Singapore
SINGAPORE, Oct. 5, 2021 /PRNewswire/ -- According to the Ministry of Health
Singapore
2021-10-05 10:00
2320
Zuellig Pharma Receives EcoVadis Platinum Medal in 2021 For Sustainability
SINGAPORE, Oct. 5, 2021 /PRNewswire/ -- Zuellig Pharma, a leading healthcare
services provider inAsia, has been awarded the Platinum Medal 2021 by
sustainability ratings specialistEcoVadis
2021-10-05 09:00
5581
Himalaya Therapeutics Announces Submission in Mainland China of IND Applications for its CAB-AXL-ADC to treat sarcomas and NSCLC, its CAB-ROR2-ADC to treat melanoma and NSCLC
SHANGHAI and SAN DIEGO, Oct. 5, 2021 /PRNewswire/ -- Himalaya Therapeutics ("Himalaya"), a clinical-stage biopharmaceutical company focused on development and commercialization inGreater China, of a novel class of investigational antibody therapeutics for the treatment of solid tumor cancer, whi...
2021-10-05 01:08
2124
RedHill Biopharma Reports Further Analysis of Phase 2/3 Data Including a 62% Reduction in Mortality with Oral Opaganib in Moderately Severe COVID-19 Patients
TEL AVIV, Israel and RALEIGH, N.C., Oct. 4, 2021 /PRNewswire/ -- RedHill
Biopharma Ltd.
2021-10-04 21:24
12243
Kintor Pharma Announces First Patient Dosing in Phase III Clinical Trial of Proxalutamide for the Treatment of Hospitalized COVID-19 Patients in US
SUZHOU, China, Oct. 4, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, announced today that onOctober 1 its phase III clinical trial of proxalutamide for the ...
2021-10-04 16:30
10615
Debiopharm Encourages Breakthrough Cancer Research in Japan Through its Competitive JCA Mauvernay Award
LAUSANNE, Switzerland, Oct. 4, 2021 /PRNewswire/ -- Debiopharm (
www.debiopharm.com
2021-10-04 15:00
2133
New Research in Kosovo Highlights Connection Between Children's Poor Vision and Learning and Development
Study underscores link between uncorrected poor vision and children's potential DALLAS, Oct. 4, 2021 /PRNewswire/ -- A new study, a collaboration of the Vision Impact Institute, EdGuard Institute, and ESSILOR's Vision for Life™ social impact fund, offers new insight into the correlation between ...
2021-10-04 12:30
3028
Chiranya Prachaseri recognized as Asia's Most Inspiring Executives
BANGKOK, Oct. 4, 2021 /PRNewswire/ -- "As recognized by the ACES Awards 2021 for theAsia's Most Inspiring Executives award, it is such a great honor not only me but also everyone in Cryoviva for being a team player and builder together", said Chiranya Prachaseri, Chief Executive Officer of Cryovi...
2021-10-04 10:30
3638
Brii Bio Presents Positive Phase 3 Data on BRII-196/BRII-198, the Company's SARS-CoV-2 Monoclonal Neutralizing Antibody Combination Therapy, in an Oral Late-Breaker Presentation at IDWeek 2021
DURHAM, N.C.and BEIJING, Oct. 4, 2021 /PRNewswire/ -- Brii Biosciences
2021-10-04 08:00
4785
Colorectal cancer diagnoses dropped over 40% during COVID-19 pandemic, new study shows
VIENNA, Oct. 4, 2021 /PRNewswire/ -- The number of colorectal cancer (CRC) cases diagnosed fell dramatically by 40% in a year during the COVID-19 pandemic, new research presented today at UEG Week Virtual 2021 has shown. The research, which was conducted across multiple hospitals in Spain, compa...
2021-10-04 06:00
2834
In Lead-up to Breast Cancer Awareness Month, New Hologic Global Women's Health Index Finds Globally Most Women Were Not Checked for Any Cancer in Past Year
Worldwide, 88% of women said in 2020 that they had not been tested for any type of cancer in the past 12 months. Most women believe checkups help improve health, but 40% haven't talked to a healthcare professional in the past 12 months. WASHINGTON, Oct. 2, 2021 /PRNewswire/ -- In the lead-up to ...
2021-10-02 12:18
3929
World's Leading Neuroscientists Unveil Research on COVID-19's Impact on the Brain, Understanding Migraine Pathophysiology, Solving the Mystery of Sleep, Biomarkers in Traumatic Brain Injury and More at 25th Biennial World Congress of Neurology from October 3-7
LONDON, Oct. 2, 2021 /PRNewswire/ -- The impact COVID-19 has on the brain, understanding migraine pathophysiology, solving the mystery of sleep by "Lighting Up the Brain," blood biomarkers for traumatic brain injury and more groundbreaking research will be unveiled by the world's leading neurosci...
2021-10-02 12:10
4934
CStone presents ARROW study data for GAVRETO® (pralsetinib) in Chinese patients with RET-mutant medullary thyroid cancer (MTC) for the first time in a late breaking oral abstract session at the 90th Annual Meeting of the American Thyroid Association 2021
* Primary efficacy results showed GAVRETO had robust and durable anti-tumor activity in the Chinese patients with advanced or metastatic RET-mutant medullary thyroid cancer (MTC), with a confirmed objective response rate (ORR) of 73.1%. And the 9-month duration of response (DOR) rate was 100% ...
2021-10-02 08:30
10478
Joint Commission International Publishes Second Edition of International Accreditation Standards for Home Care
Standards and requirements in latest edition become effective 1 April 2022 OAK BROOK, Ill., Oct. 1, 2021 /PRNewswire/ -- Joint Commission International (JCI) today publishedJoint Commission International Accreditation Standards for Home Care, Second Edition. The manual provides home care organiza...
2021-10-01 20:00
3121
I-Mab Announces Upcoming Participation at October Conferences
SHANGHAI and GAITHERSBURG, Md., Oct. 1, 2021 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced its participation in the following conferences in October...
2021-10-01 20:00
14982
Medidata Veterans Rama Kondru and Sastry Chilukuri Named co-CEOs
SINGAPORE and SYDNEY, Oct. 1, 2021 /PRNewswire/ -- Medidata, a Dassault
Systèmes company, recently namedRama Kondru
2021-10-01 09:00
4108
Binhai sets ambitious biomedical goals with support of key companies
TIANJIN, China, Sept. 30, 2021 /PRNewswire/ -- A news report by chinadaily.com.cn: The Binhai New Area in North China's port city of Tianjin has gathered together more than 1,500 biomedical companies that have made great scientific achievements in key areas, such as recombinant proteins and stem...
2021-10-01 01:08
2053
Week's Top Stories
Most Reposted
CityUHK and University of Cambridge establish Centre for Advanced and Smart Manufacturing to shape Hong Kong's Industry 5.0 future
[Picked up by 293 media titles]
2026-09-22 18:37
Agoda Releases AI Developer Report 2026: Agentic AI Adoption Outpaces Enterprise Readiness Across Southeast Asia and India
[Picked up by 292 media titles]
2026-09-24 10:30
CGS International Convenes China-ASEAN Business Leaders Summit to Deepen Capital Connectivity Across the Corridor
[Picked up by 281 media titles]
2026-09-23 09:00
HLB's Flagship CIO Fund Launched with Strategic Alliance with Lombard Odier
[Picked up by 276 media titles]
2026-09-28 23:04
Malaysia Calls for Shift from Halal-Certified to Halal-Competitive as ASEAN Targets USD5 Trillion Global Halal Economy
[Picked up by 275 media titles]
2026-09-25 14:45
Most Read
Brightray Signs Prefabricated Module Sales Framework Agreement for Planned 40MW AI Data Center Project in Macao
2026-09-25 20:30
12913
Envision Energy Secures TÜV SÜD Certificate for Wind Farm Control System, Strengthening Long-Term Resilience for Future Energy Systems
2026-09-25 20:11
11629
ULTRALOQ Launches Next-Generation Smart Lock Collection: Refining Home Entry with Natural, Intelligent and Trusted Access Solutions
2026-09-26 02:46
10574
